The Essential Therapy Guide to Cancer, Hematologic Disorders, and Supportive Care--Updated with the Latest Treatment RegimensMore than 500 treatment regimensA Doody s Core Title for 2019!
I Am Not My Breast Cancer gathers the warm, loving, frank, and informed voices of more than eight hundred women—from every state in the nation and from continents as far away as Australia and Africa—who reveal their fears, trade advice, share experiences, and express their deepest, most intimate concerns.
The luminous true story of a friendship that shed the boundaries of the doctor-patient relationship and became less a confrontation with death than a celebration of the joys of lifeWhen young gynecologic oncology fellow Lois Ramondetta was first summoned to the room of a new patient, neither she nor the forty-nine-year-old professor of religion she encountered named Deborah Sills thought they had much in common.
A fundamental and groundbreaking reassessment of how we view and manage cancer When we think of the forces driving cancer, we don't necessarily think of evolution.
Novel Approaches and Strategies for Biologics, Vaccines and Cancer Therapies takes a look at the current strategies, successes and challenges involved with the development of novel formulations of biologics, vaccines and cancer therapy.
Probably Nothing by Matilda Tristram - a moving, funny and inspiring graphic memoir by a woman who discovered she had cancer whilst she was pregnant'This deeply personal memoir, written as a graphic novel is one of the most darkly funny, bittersweet and moving cartoons you will ever come across (and that includes the hunting scene in Bambi).
Men who have completed prostate cancer treatment often find themselves facing new challenges and setbacks that do not necessarily recede along with the cancer.
The breast cancer guide every woman needs for herself, her best friend, and her sister-a warm, practical, relatable handbook, that dispels the terror, taking you step-by-step through the process, from diagnosis to post-treatment.
Health literacy is a critical skill for engaging in healthy behaviors to reduce disease risk and improve health outcomes across the continuum of cancer care.
In a workshop organized by the Clinical Research roundtable, representatives from purchaser organizations (employers), payer organizations (health plans and insurance companies), and other stakeholder organizations (voluntary health associations, clinical researchers, research organizations, and the technology community) came together to explore: What do purchasers and payers need from the Clinical Research Enterprise?
Most industries have plunged into data automation, but health care organizations have lagged in moving patients' medical records from paper to computers.
The model for risk assessment of nutrients used to develop tolerable upper intake levels (ULs) is one of the key elements of the developing framework for Dietary Reference Intakes (DRIs).
Based on a thorough review of the scientific evidence, this book provides the most authoritative assessment yet of the relationship between dietary and nutritional factors and the incidence of cancer.
The National Cancer Policy Board and the Board on Science, Engineering, and Economic Policy convened a workshop in January 2004 on "e;Economic Models of Colorectal Cancer (CRC) Screening in Average-Risk Adults"e;.
The third in a series of congressionally mandated reports on Gulf War veterans' health, this volume evaluates the long-term, human health effects associated with exposure to selected environmental agents, pollutants, and synthetic chemical compounds believed to have been present during the Gulf War.
There is growing interest in using performance measurement as a means of holding federal, state, and local health agencies accountable for their use of public funds.
Consumer health websites have garnered considerable media attention, but only begin to scratch the surface of the more pervasive transformations the Internet could bring to health and health care.
The Roundtable on Environmental Health Sciences, Research, and Medicine wanted to address the link between environmental factors and the development of cancer in light of recent advances in genomics.
In the nearly 40 years since implementation of federal regulations governing the protection of human participants in research, the number of clinical studies has grown exponentially.
In a workshop organized by the Clinical Research roundtable, representatives from purchaser organizations (employers), payer organizations (health plans and insurance companies), and other stakeholder organizations (voluntary health associations, clinical researchers, research organizations, and the technology community) came together to explore: What do purchasers and payers need from the Clinical Research Enterprise?
The American Society of Clinical Oncology (ASCO) predicts that by 2020, there will be an 81 percent increase in people living with or surviving cancer, but only a 14 percent increase in the number of practicing oncologists.
The NCI-sponsored cooperative groups have made important contributions to improving treatment for many types of cancer, including breast, ovarian, colorectal, and childhood cancers.
